Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
6,300.00
+250.00 (4.13%)
Jun 29, 2026, 3:30 PM KST
84.48% (1Y)
| Market Cap | 174.37B +83.1% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 104.41 |
| Forward PE | n/a |
| Dividend | 30.00 (0.50%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 1,010,757 |
| Open | 5,850.00 |
| Previous Close | 6,050.00 |
| Day's Range | 5,850.00 - 6,760.00 |
| 52-Week Range | 3,380.00 - 15,960.00 |
| Beta | 0.68 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |